1999
DOI: 10.1021/cr980435t
|View full text |Cite
|
Sign up to set email alerts
|

Potential Technetium Small Molecule Radiopharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

4
388
0
5

Year Published

2000
2000
2012
2012

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 568 publications
(397 citation statements)
references
References 79 publications
(178 reference statements)
4
388
0
5
Order By: Relevance
“…The gamma-emitting radionuclide 99m Tc and its Group VII congener 186/188 Re have found wide-ranging applications in radiodiagnosis [1][2][3][4][5][6] and radiotherapy [7,8], respectively. The optimal nuclear properties of 99m Tc (γ-emitter, E max = 140 keV, t 1/2 = 6 h), as well as its convenient availability from 99 Mo/ 99m Tc generator system [9], have made 99m Tc radiopharmaceuticals virtually ideal for imaging low capacity high density receptors by deploying SPECT (single photon emission computerized tomography), while both isotopes 186 Re (t 1/2 = 90.64 h, E max = 1.1 MeV) and 188 Re (t 1/2 = 17 h, E max = 2.1 MeV) are suitable for therapeutic use b y means of β-irradiation.…”
Section: Introductionmentioning
confidence: 99%
“…The gamma-emitting radionuclide 99m Tc and its Group VII congener 186/188 Re have found wide-ranging applications in radiodiagnosis [1][2][3][4][5][6] and radiotherapy [7,8], respectively. The optimal nuclear properties of 99m Tc (γ-emitter, E max = 140 keV, t 1/2 = 6 h), as well as its convenient availability from 99 Mo/ 99m Tc generator system [9], have made 99m Tc radiopharmaceuticals virtually ideal for imaging low capacity high density receptors by deploying SPECT (single photon emission computerized tomography), while both isotopes 186 Re (t 1/2 = 90.64 h, E max = 1.1 MeV) and 188 Re (t 1/2 = 17 h, E max = 2.1 MeV) are suitable for therapeutic use b y means of β-irradiation.…”
Section: Introductionmentioning
confidence: 99%
“…The continuing expansion of the coordination chemistry of the Group VII elements technetium and rhenium reflects the application of their radionuclides to the development of radiopharmaceuticals [1][2][3][4][5]. 99m Tc-based radiopharmaceuticals continue to provide the mainstay in diagnostic nuclear medicine due to the optimal nuclear properties (t 1/2 = 6.02 h, E g = 142 keV) and easy availability from 99 Mo/ 99m Tc generator [6].…”
Section: Introductionmentioning
confidence: 99%
“…An ideal conceptual design would provide six-coordinate {Re=N-R} complexes with maximum stability, which hold a pre-organized pentadentate ligand with four coplanar donor atoms and the fifth group perpendicular to the basal plane and trans to the metal-imido bond. 2 ] with 1 utilizing triethylamine as base to neutralize the HCl produced in situ. We herein report the synthesis of a novel '4+2' rhenium(IV) complex 4 whose structure is defined by a highly distorted six-coordinate geometry featuring the [N 3 S] donor set of ligand 3, a partially self-condensed thiazolidine derivative of ligand 1, whose N 3 S donors define a trapezoidal plane and the [NS] donors of the doubly deprotonated form of 2-aminothiophenol, (NHC 6 H 4 S) 2− , in the apical positions.…”
Section: Introductionmentioning
confidence: 99%
“…The widespread contemporary interest in the development of technetium and rhenium radiopharmaceuticals [1][2][3][4][5] has fostered a dramatic expansion of the coordination chemistry of these metals. One persistent strategy has focused on developing effective chelating ligands for the robust and ubiquitous {MO} 3+ core (M = Tc, Re).…”
Section: Introductionmentioning
confidence: 99%